Susquehanna International Group
PSTVZ

Susquehanna International Group’s PLUS THERAPEUTICS, Inc. Series S Warrant PSTVZ Stock Holding History

Susquehanna International Group’s Portfolio PSTVZ Stock Details PSTVZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-51,271
Closed – – 11252
2019
Q4 		$0 Sell
51,271
-93,659
-65% -$543 ﹤0.01% 11120
2019
Q3 		$1K Buy
+144,930
New +$1.75K ﹤0.01% 10070

Other funds holding PSTVZ

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group's PSTVZ Position: Q1 2020 in Review

Susquehanna International Group sold out of PLUS THERAPEUTICS, Inc. Series S Warrant (PSTVZ) in Q1 2020, closing a stake of 51,271 shares.

Susquehanna International Group first reported a position in PSTVZ in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q3 2019. 5 funds tracked by Wall St. Rank hold PSTVZ as of Q1 2020.

  • Susquehanna International Group reported no remaining PLUS THERAPEUTICS, Inc. Series S Warrant position as of Q1 2020 after selling out during the quarter.
  • Susquehanna International Group sold 51,271 PLUS THERAPEUTICS, Inc. Series S Warrant shares in Q1 2020.
  • Susquehanna International Group first reported a position in PLUS THERAPEUTICS, Inc. Series S Warrant in Q3 2019 and held it in 2 quarters.
  • Susquehanna International Group's PLUS THERAPEUTICS, Inc. Series S Warrant position peaked at $1K in Q3 2019.
  • 5 funds tracked by Wall St. Rank held PLUS THERAPEUTICS, Inc. Series S Warrant as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.